Dyne Therapeutics, Inc. (DYN)
19.42
-0.27
(-1.37%)
USD |
NASDAQ |
Dec 11, 16:00
19.42
0.00 (0.00%)
After-Hours: 05:31
Dyne Therapeutics Cash from Investing (Quarterly): -37.96M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | -587.93M |
| CEL-SCI Corp. | 0.00 |
| AIM ImmunoTech, Inc. | 0.296M |
| IGC Pharma, Inc. | -0.374M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -90.78M |
| Cash from Financing (Quarterly) | 217.33M |
| Free Cash Flow | -397.01M |
| Free Cash Flow Per Share (Quarterly) | -0.7754 |
| Free Cash Flow to Equity (Quarterly) | -109.35M |
| Free Cash Flow to Firm (Quarterly) | -107.06M |
| Free Cash Flow Yield | -17.48% |